Zacks Research Weighs in on Teladoc Health FY2025 Earnings

Teladoc Health, Inc. (NYSE:TDOC) – Zacks Research decreased their FY2025 earnings per share estimates for shares of Teladoc Health in a research note issued to investors on Tuesday, February 17th. Zacks Research analyst Team now expects that the health services provider will earn ($0.90) per share for the year, down from their prior estimate of ($0.83). Zacks Research has a “Hold” rating on the stock. The consensus estimate for Teladoc Health’s current full-year earnings is ($1.16) per share.

A number of other equities research analysts have also recently issued reports on the stock. Weiss Ratings reissued a “sell (e+)” rating on shares of Teladoc Health in a research note on Monday, December 29th. BMO Capital Markets started coverage on shares of Teladoc Health in a research report on Thursday, November 13th. They issued a “market perform” rating and a $8.00 target price on the stock. Bank of America reduced their price target on shares of Teladoc Health from $9.00 to $8.00 and set a “neutral” rating for the company in a research report on Tuesday, November 25th. Citigroup decreased their price target on shares of Teladoc Health from $10.00 to $9.00 and set a “neutral” rating on the stock in a research note on Friday, January 9th. Finally, Evercore cut their price objective on Teladoc Health from $9.00 to $8.00 and set an “in-line” rating for the company in a research note on Thursday, October 30th. Three analysts have rated the stock with a Buy rating, twelve have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $9.12.

Teladoc Health Stock Up 4.8%

Teladoc Health stock opened at $4.89 on Friday. The company has a debt-to-equity ratio of 0.71, a current ratio of 2.70 and a quick ratio of 2.60. The stock has a market capitalization of $866.94 million, a PE ratio of -3.82 and a beta of 2.12. The business has a 50 day simple moving average of $6.28 and a 200-day simple moving average of $7.29. Teladoc Health has a 12 month low of $4.40 and a 12 month high of $13.60.

Insider Buying and Selling

In related news, insider Fernando M. Rodrigues sold 4,209 shares of the company’s stock in a transaction dated Wednesday, December 3rd. The shares were sold at an average price of $7.48, for a total value of $31,483.32. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Carlos Nueno sold 3,897 shares of the stock in a transaction that occurred on Tuesday, December 2nd. The shares were sold at an average price of $7.49, for a total transaction of $29,188.53. Following the completion of the sale, the insider directly owned 27,175 shares of the company’s stock, valued at approximately $203,540.75. This trade represents a 12.54% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have sold 33,288 shares of company stock valued at $251,684. 0.58% of the stock is currently owned by company insiders.

Institutional Trading of Teladoc Health

Hedge funds and other institutional investors have recently modified their holdings of the business. PNC Financial Services Group Inc. increased its position in shares of Teladoc Health by 177.7% during the fourth quarter. PNC Financial Services Group Inc. now owns 4,391 shares of the health services provider’s stock valued at $31,000 after acquiring an additional 2,810 shares during the last quarter. IFP Advisors Inc increased its holdings in Teladoc Health by 412.1% in the 3rd quarter. IFP Advisors Inc now owns 3,989 shares of the health services provider’s stock valued at $31,000 after purchasing an additional 3,210 shares during the last quarter. Aster Capital Management DIFC Ltd raised its position in Teladoc Health by 101.1% in the third quarter. Aster Capital Management DIFC Ltd now owns 4,823 shares of the health services provider’s stock valued at $37,000 after purchasing an additional 2,425 shares during the period. International Assets Investment Management LLC acquired a new position in Teladoc Health during the fourth quarter worth $45,000. Finally, Bayforest Capital Ltd purchased a new position in shares of Teladoc Health during the third quarter worth $58,000. 76.82% of the stock is owned by institutional investors and hedge funds.

Teladoc Health Company Profile

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.